SCI Abstract

search
+
Evolving landscape of nasopharyngeal carcinoma therapy
Evolving landscape of nasopharyngeal carcinoma therapy
Propelled by a growing understanding of nasopharyngeal carcinoma pathogenesis through elucidation of its genomic and immun...
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence
The role of driver gene mutations in sustaining tumor growth at metastatic sites is poorly understood. SMAD4 inactivation ...
Radiopharma pipeline builds ahead of key data
Investment continues as the field awaits phase 3 readouts for next-generation radioligand therapies in 2026.
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
Immunotherapy has shown limited success in acute myeloid leukemia (AML), indicating an incomplete understanding of the und...
Hijacked brain–gut polysynaptic pathway promotes colorectal cancer growth
Hijacked brain–gut polysynaptic pathway promotes colorectal cancer growth
Bidirectional signaling between the brain and peripheral tumors plays a major part in cancer biology but is poorly underst...
Author Correction: Evolving landscape of nasopharyngeal carcinoma therapy
Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, ChinaKar Wei Chi...
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Cabozantinib is an oral multikinase inhibitor approved for treatment in metastatic renal cell carcinoma (RCC). We conducte...
An antibody–toxin conjugate enhances innate immune cell responses in tumors
An antibody–toxin conjugate enhances innate immune cell responses in tumors
Traditional antibody–toxin conjugates (ATCs) are designed to target and destroy cancer cells. We present an ATC that...
Hallmarks of artificial intelligence contributions to precision oncology
Hallmarks of artificial intelligence contributions to precision oncology
The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care. In this Review, we di...
Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
Tissue remodeling and cell plasticity in the mammary gland are activated by multilineage communications; however, the dyna...
Long-term results with nivolumab and ipilimumab in melanoma
Immune checkpoint inhibitors such as PD-1 inhibitors and antibodies to CTLA-4 provide much better survival rates for patie...
Glioblastoma’s widespread integration into neuronal networks
A few years ago, independent research groups studying brain-cancer biology demonstrated that neurons form synaptic connect...
Neutrophils take their PICk to promote breast cancer
Neutrophils take their PICk to promote breast cancer
Tumor-infiltrating neutrophils can have either pro-tumoral potential or anti-tumoral potential. Physical contact between h...
Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors
Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors
Targeting MALT1’s paracaspase activity has been explored for B cell lymphoma and solid tumors. While the role of MAL...
First, novel and paradigm-shifting
First, novel and paradigm-shifting
In delineating scientific findings, authors should avoid assertions of primacy and novelty, in favor of measured descripti...
A deep dive into transmissible cancer evolution in bivalve mollusks
A deep dive into transmissible cancer evolution in bivalve mollusks
Transmissible cancer affects marine bivalve mollusks worldwide, but how genetic mechanisms influence cancer evolution and ...
Myeloma evades T cell-engaging therapies
Myeloma evades T cell-engaging therapies
Chimeric antigen receptor T cells and T cell-redirecting bispecific antibody therapies are changing the landscape of myelo...
Endothelium directs fat remodeling in cachexia
Endothelium directs fat remodeling in cachexia
Certain cancers disrupt metabolism, leading to the wasting syndrome known as cachexia. How tumor-induced mediators of cach...
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy
Dendritic cells (DCs) are antigen-presenting myeloid cells that regulate T cell activation, trafficking and function...
Turning a failing PhD around
Turning a failing PhD around
Charles Swanton obtained a PhD from the Imperial Cancer Research Fund Laboratories (now the Francis Crick Institute) in 19...
Targeting network circuitry in glioma
Targeting network circuitry in glioma
The nervous system regulates cancer progression, and the importance of neuron–glioma communication in tumor growth i...
The never-abating excitement for targeted therapies
In combining technical innovation with foundational research, targeted therapies remain at the forefront of oncology drug ...
Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia
Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia
Telomerase enables replicative immortality in most cancers including acute myeloid leukemia (AML). Imetelstat is a first-i...
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target
Safely expanding indications for cellular therapies has been challenging given a lack of highly cancer-specific surface ma...
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Despite improving outcomes, 40% of patients with newly diagnosed multiple myeloma treated with regimens containing daratum...
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
Despite recent advances in the treatment of acute myeloid leukemia (AML), there has been limited success in targeting surf...
An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma
An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma
In vitro-transcribed (IVT) mRNA has arisen as a rapid method for the production of nucleic acid drugs. Here, we have const...
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which...
Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma
Glutamine mimicry suppresses tumor progression through asparagine metabolism in pancreatic ductal adenocarcinoma
In pancreatic ductal adenocarcinoma (PDAC), glutamine is a critical nutrient that drives a wide array of metabolic and bio...
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Targeting pancreatic cancer metabolic dependencies through glutamine antagonism
Pancreatic ductal adenocarcinoma (PDAC) cells use glutamine (Gln) to support proliferation and redox balance. Early attemp...
Load More
format_indent_increase